Opportunities in traditional pharma companies with a focus on domestic formulations and US generic drugs are drying up ...

Opportunities in traditional pharma companies with a focus on domestic formulations and US generics are drying up because of a slowdown in new approvals and regulatory issues.

Its raining IPOs at Dalal Street as the month of July will be witnessing more than a dozen IPOs hitting Dalal Street in the ...

The IPO of GNG Electronics fetched nearly 42.14 lakh applications as the issue fetched bids worth Rs 49,745 crore for its net ...